A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...